| Tag | Content |
|---|
EnhancerAtlas ID | HS139-30651 | Organism | Homo sapiens | Tissue/cell | Myotube | Coordinate | chr2:171127140-171128500 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_59761 | chr2:171121618-171181709 | Ly4 |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| Enhancer Sequence | GCCCTGTATA GAAGCCCTCC ATTGCCTGAC AGTCACTGCT AGAGCCATTT TCTATGTTTC 60
CTCCAACGTG GCAAGGCTGT TGGAATGGTA GTTTAGGAGA GGACGTAGCA GGGTTTGAGA 120
GGGTTGGAGG TGTGACCCCA GGGAAGAAGA GTACTCAACA AGGGAGCTAC AACCGATGGC 180
TAGCCATTGC ATGAACTTAA ACATTTGGCC CTTTTCACTG TGTGTTTCAT AAGCCTTTTG 240
TAGTTGAATT TGGATGGTAA ATATGAGATA AAGGAAGAAA AGTATTTTAT TCCAACAACC 300
ACTACAGCCA GTTCCACATC CATGGAGTTG GGTAACACTT CACCGTTTAT AAGCATATCC 360
ACATTTATTA TCTAAGTTAA TTCTCAGACC TTGAAAGGCA GTTATATTTA TTTGCCAGAT 420
ATAGAAATTG GAGCCGGTAA AGATTGCTAC TAAGTAGCAA CTTTGGAAGT CACATGCAGG 480
TTTTGTAACC TGGTTTCCAG GGGTTCAGAA ATGAGAAAGA CTTCTTCCTT TCCCCTTCAG 540
GTATTATTTT AGTATTTGTT AATGGAGTAA AGAAATGGGT GGGGCACAGG GAATGTTAAA 600
GTGGTGAACA TTTAGCCTTT AACTGGAAAG CAGCATAATC TTAAAATAAA TGTTATTTTG 660
TTTTTAAATA ATACACACAT TTCCTTCAAC AAAATGGAAT CTTATAGGTA GCTCATACAT 720
CTCTTGAATA GGGGCCTCTG GTGCCTACAG ATATAAATAA ATCACACTGA GAGAATGGTG 780
AACCATGAAA TGACTCTGTT AACATGTCAT CTGTCTAGAA TATATTTTCA ACTCTCCAAC 840
AGAAGTGTCT CAATTATGAA GGGAGGTGGC CTACCAAAGT TGATACTTTG ATATTTGATG 900
CTTTTAACCT CCTCCATCAG CTGCCTTTGC CTAAGTGTGG AATCTGGCCC AGTGCATAGA 960
GTACAACGTG GCCTAATGGC TGAGAGTCAT TGTAACTGGT GATTTTAACA TGCAATGAAC 1020
TCTGAAGCTC CTCAAACTGT GCTATCTTGT GAAGGCATGT ATCAGTGCTA CTTGTCTGGT 1080
CTTATTAAGG AATTCTGAAA ATTGCTAATT GTTATAATAA GAATTTTAAC CACAAACAAG 1140
CCAAATTTAC TGAATTCTTC CTTTATGCCC AGCACTGACT GATACTATAG TGGGCTTCGG 1200
AAATGTTCCC AAAATGACTT TTGTTTTTAA GTTACTCTGA ATGTAGTCTC AGAATTTGAG 1260
GTGGGGACTA GTAGGTTTTA GTGGCCTATT TGTATTCAGG TTTCAGTATA TAATAATGTG 1320
AAAATAGCTC TTTGTATCTA GTAAACTTGC AGATGCCAGC 1360
|
| |
|
|
|
